Impact of graphene oxide nano sheets loaded with chemotherapeutic drug on tumor cells
Source abstract
Abstract
Graphene oxide (GO) nanosheet is a drug delivery system due to its structural properties, which can be augmented in presence of folic acid (FA). This study aimed to compare the efficacy of GO as a passive (GO/DOX) and active (GO/FA/DOX) forms for delivering doxorubicin (DOX). These two forms of conjugates were characterized before and after loading of DOX to confirm the conjugation as well as their properties including size and thermal stability. Using Ehrlich ascites carcinoma (EAC) cell line, the antitumor effect was evaluated by MTT assay in vitro and cell count; tumor cell cycle and apoptosis were evaluated by flow cytometry in vivo. The results showed that the loading percentages of DOX onto GO (GO/DOX) and GO/FA/DOX were 91% and 83%, respectively. TEM, FT-IR, and TGA confirmed the nano size, physical conjugation by shifted groups, and thermal stability. In vitro, the conjugates induced similar decrease of EAC cell viability, but still lower than those of free DOX. Treatment of EAC-bearing mice with GO/DOX or GO/FA/DOX forms induced significant decreases of the total numbers of EAC cells by 79% and 97%, respectively, as compared with free DOX (97%). DOX, GO/DOX, and GO/FA/DOX induced cell cycle arrest at G0, G1, and S phase, respectively. These conjugates also induced significant apoptosis with different profiles on viable, early, and late apoptotic EAC cells. In conclusion, loading DOX on GO nanosheet activated with FA can induce antitumor effect similar to those of free DOX but with different mechanisms.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Graphene research and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (31)
Show source-provided references
1. Akhavan O, Ghaderi E, Akhavan A (2012) Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. Biomaterials 33:8017–8025. https://doi.org/10.1016/j.biomaterials.2012.07.04010.1016/j.biomaterials.2012.07.040 ↗
2. Bhatia S (2016) Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications in natural polymer drug delivery systems: nanoparticles, plants, and algae. Springer International Publishing, Switzerland, pp 33–93. https://doi.org/10.1007/978-3-319-41129-3_210.1007/978-3-319-41129-3_2 ↗
3. Chen Y et al (2014) Multifunctional graphene oxide-based triple stimuli-responsive. Nanotheranostics Adv Funct Mater 24:4386–439610.1002/adfm.201400221 ↗
4. Coffelt SB, de Visser KE (2015) Immune-mediated mechanisms influencing the efficacy of anticancer therapies. Trends Immunol 36:198–216. https://doi.org/10.1016/j.it.2015.02.00610.1016/j.it.2015.02.006 ↗
5. Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML (2006) The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin Immunol 121:159–17610.1016/j.clim.2006.06.006 ↗
6. Dinauer N, Balthasar S, Weber C, Kreuter J, Langer K, von Briesen H (2005) Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes. Biomaterials 26:5898–5906. https://doi.org/10.1016/j.biomaterials.2005.02.03810.1016/j.biomaterials.2005.02.038 ↗
7. Fong YT, Chen CH, Chen JP (2017) Intratumoral delivery of doxorubicin on folate-conjugated graphene oxide by in-situ forming thermo-sensitive hydrogel for breast cancer therapy. Nanomaterials (Basel) 7:388. https://doi.org/10.3390/nano711038810.3390/nano7110388 ↗
8. Geim AK, Novoselov KS (2007) The rise of graphene. Nat Mater 6:183–19110.1038/nmat1849 ↗
9. Gerard EI, Karen VH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411:342–34810.1038/35077213 ↗
10. Janes KA, Calvo P, Alonso MJ (2001) Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev 47:83–9710.1016/S0169-409X(00)00123-X ↗
11. Kamen BA, Capdevila A (1986) Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc Natl Acad Sci U S A 83:5983–5987. https://doi.org/10.1073/pnas.83.16.598310.1073/pnas.83.16.5983 ↗
12. Khan M et al (2016) Apoptosis inducing ability of silver decorated highly reduced graphene oxide nanocomposites in A549 lung cancer. Int J Nanomedicine 11:873–883. https://doi.org/10.2147/IJN.S10090310.2147/IJN.S100903 ↗
13. Khan MS, Pandey S, Bhaisare ML, Gedda G, Talib A, Wu HF (2017) Graphene oxide@gold nanorods for chemo-photothermal treatment and controlled release of doxorubicin in mice. Tumor Colloids Surf B Biointerf 160:543–552. https://doi.org/10.1016/j.colsurfb.2017.09.00110.1016/j.colsurfb.2017.09.001 ↗
14. Kim KJ, Joe YA, Kim MK, Lee SJ, Ryu YH, Cho DW, Rhie JW (2015) Silica nanoparticles increase human adipose tissue-derived stem cell proliferation through ERK1/2 activation. Int J Nanomedicine 10:2261–2272. https://doi.org/10.2147/IJN.S7192510.2147/IJN.S71925 ↗
15. Licciardi M, Giammona G, Du J, Armes SP, Tang Y, Lewis AL (2006) New folate-functionalised biocompatible block copolymer micelles as potential anti-cancer drug delivery systems. Polymer 47:2946–2955. https://doi.org/10.1016/j.polymer.2006.03.01410.1016/j.polymer.2006.03.014 ↗
16. Liu J, Kang Y, Zheng W, Song B, Wei L, Chen L, Shao L (2017) Ion-shedding zinc oxide nanoparticles induce microglial BV2 cell proliferation via the ERK and Akt signaling pathways. Toxicol Sci 156:167–178
17. Low PS, Henne WA, Doorneweerd DD (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 41:120–129. https://doi.org/10.1021/ar700081510.1021/ar7000815 ↗
18. Mahmoudi M, Simchi A, Imani M, Shokrgozar MA, Milani AS, Hafeli UO, Stroeve P (2010) A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids Surf B: Biointerfaces 75:300–309. https://doi.org/10.1016/j.colsurfb.2009.08.04410.1016/j.colsurfb.2009.08.044 ↗
19. Marcano DC et al (2010) Improved synthesis of graphene oxide. ACS Nano 4:4806–4814. https://doi.org/10.1021/nn100636810.1021/nn1006368 ↗
20. Matesanz MC et al (2013) The effects of graphene oxide nanosheets localized on F-actin filaments on cell-cycle alterations. Biomaterial 34:1562–156910.1016/j.biomaterials.2012.11.001 ↗
21. McCallion C, Burthem J, Rees-Unwin K, Golovanov A, Pluen A (2016) Graphene in therapeutics delivery: problems, solutions and future opportunities. Eur J Pharm Biopharm 104:235–250. https://doi.org/10.1016/j.ejpb.2016.04.01510.1016/j.ejpb.2016.04.015 ↗
22. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229. https://doi.org/10.1124/pr.56.2.610.1124/pr.56.2.6 ↗
23. Muazim K, Hussain Z (2017) Graphene oxide-a platform towards theranostics. Mater Sci Eng C Mater Biol Appl 76:1274–1288. https://doi.org/10.1016/j.msec.2017.02.12110.1016/j.msec.2017.02.121 ↗
24. Nasongkla N, Shuai X, Ai H, Weinberg BD, Pink J, Boothman DA, Gao J (2004) cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed Eng 43:6323–6327. https://doi.org/10.1002/anie.20046080010.1002/anie.200460800 ↗
25. Osman AM, al-Harthi SE, AlArabi O, Elshal MF, Ramadan WS, Alaama MN, al-Kreathy HM, Damanhouri ZA, Osman OH (2013) Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin-treated animals. Cancer Cell Int 13:52. https://doi.org/10.1186/1475-2867-13-5210.1186/1475-2867-13-52 ↗
26. Patel P, Kansara K, Senapati VA, Shanker R, Dhawan A, Kumar A (2016) Cell cycle dependent cellular uptake of zinc oxide nanoparticles in human epidermal cells. Mutagenesis 31:481–490. https://doi.org/10.1093/mutage/gew01410.1093/mutage/gew014 ↗
27. Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S (2009) Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. Biomaterials 30:5757–5766. https://doi.org/10.1016/j.biomaterials.2009.07.02010.1016/j.biomaterials.2009.07.020 ↗
28. Siriviriyanun A, Popova M, Imae T, Kiew LV, Looi CY, Wong WF (2015) Preparation of graphene oxide/dendrimer hybrid carriers for delivery of doxorubicin. Chem Eng J 281:771–781. https://doi.org/10.1016/j.cej.2015.07.02410.1016/j.cej.2015.07.024 ↗
29. Stella B et al (2000) Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci 89:1452–1464. https://doi.org/10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p ↗
30. Wu S, Zhao X, Cui Z, Zhao C, Wang Y, Du L, Li Y (2014) Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells. Int J Nanomedicine 9:1413–1421. https://doi.org/10.2147/IJN.S5794610.2147/IJN.S57946 ↗
31. Zhao GX, Li JX, Wang XK (2011) Kinetic and thermodynamic study of 1-naphthol adsorption from aqueous solution to sulfonated graphene nanosheets. Chem Eng J 173:185–19010.1016/j.cej.2011.07.072 ↗